Leriglitazone has met the primary endpoint in NEXUS, the pivotal trial for pediatric patients with cerebral AdrenoleukodystrophyMarch 24, 2025Read article
Minoryx announces dosing of the first patient with leriglitazone in the phase 2a study in Rett syndrome (TREE study) 4 March 2025March 24, 2025Read article
Aura Biosciences Reports Third Quarter 2024 Financial Results and Business HighlightsMarch 24, 2025Read article
Aura Biosciences to Participate in the 7th Annual Evercore ISI HealthCONx ConferenceMarch 24, 2025Read article
Aura Biosciences Announces Additional Data from Ongoing Phase 1 Trial in Non-Muscle Invasive Bladder Cancer to be Presented as a Late-Breaking Abstract at the 40th Annual European Association of Urology CongressMarch 24, 2025Read article
CuraSen Therapeutics Appoints Kathleen Sereda Glaub Chief Executive OfficerMarch 24, 2025Read article
CuraSen Therapeutics Announces First Subject Treated with CuraAX (CST-3056) in a Phase 1 Clinical TrialMarch 24, 2025Read article
Glycomine Receives FDA Fast Track Designation for GLM101 for the Treatment of PMM2-CDGNovember 18, 2024Read article
Aura Biosciences Reports Second Quarter 2024 Financial Results and Business HighlightsNovember 18, 2024Read article
